These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37796197)
1. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data. Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197 [TBL] [Abstract][Full Text] [Related]
2. Comparison of SEER Treatment Data With Medicare Claims. Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121 [TBL] [Abstract][Full Text] [Related]
3. Utility of the SEER-Medicare data to identify chemotherapy use. Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169 [TBL] [Abstract][Full Text] [Related]
4. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409 [TBL] [Abstract][Full Text] [Related]
5. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Mettlin CJ; Menck HR; Winchester DP; Murphy GP Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans. Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Gold HT; Do HT Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533 [TBL] [Abstract][Full Text] [Related]
8. Unveiling SEER-CAHPS®: a new data resource for quality of care research. Chawla N; Urato M; Ambs A; Schussler N; Hays RD; Clauser SB; Zaslavsky AM; Walsh K; Schwartz M; Halpern M; Gaillot S; Goldstein EH; Arora NK J Gen Intern Med; 2015 May; 30(5):641-50. PubMed ID: 25586868 [TBL] [Abstract][Full Text] [Related]
9. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis. Elkin EB; Ishill N; Riley GF; Bach PB; Gonen M; Begg CB; Schrag D J Natl Cancer Inst; 2008 Jul; 100(14):1013-21. PubMed ID: 18612131 [TBL] [Abstract][Full Text] [Related]
10. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment. Lin CC; Virgo KS Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987 [TBL] [Abstract][Full Text] [Related]
12. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database. Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406 [TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries. Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634 [TBL] [Abstract][Full Text] [Related]
15. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. Wang K; Sheets NC; Basak R; Chen RC Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry. Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070 [TBL] [Abstract][Full Text] [Related]
17. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392 [TBL] [Abstract][Full Text] [Related]
18. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973 [TBL] [Abstract][Full Text] [Related]
19. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of trends in the cost of initial cancer treatment. Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]